postinflammatory hyperpigmentation
Jump to navigation
Jump to search
Etiology
- skin infections
- allergic reactions
- trauma (burns)
- drug reaction
- phototoxic eruptions
- ultrasound
- radiofrequency lasers
- light-emitting diodes
- micro-dermabrasion
- inflammatory skin disorders
Epidemiology
- negative impact on a patient's quality of life, especially people with skin of color[2]
Pathology
- reactive hypermelanosis
- increased production or deposition of melanin into the epidermis or dermis by labile melanocytes[2]
Clinical manifestations
- epidermal hypermelanosis appear tan, brown, or dark brown
- dermal hypermelanosis has a blue-gray discoloration[2]
Management
- topical azelaic acid
- topical retinoids[2]
- cosmetics
More general terms
References
- ↑ 1.0 1.1 Medical Knowledge Self Assessment Program (MKSAP) 17, American College of Physicians, Philadelphia 2015
- ↑ 2.0 2.1 2.2 2.3 2.4 Callender VD, St Surin-Lord S, Davis EC, Maclin M. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations. Am J Clin Dermatol. 2011 Apr 1;12(2):87-99 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21348540
- ↑ 3.0 3.1 3.2 Schwartz RA, Elston DM (images) Medscape: Postinflammatory Hyperpigmentation http://emedicine.medscape.com/article/1069191-overview
- ↑ 4.0 4.1 DermNet NZ. Postinflammatory hyperpigmentation (images) http://www.dermnetnz.org/colour/postinflammatory-pigmentation.html